Whalegun
Home

AbbVie ABBV paid Brownstein Hyatt Farber Schreck $90K for lobbying in Q1 2026 · Health Issues, Consumer Issues

Trade details

Type
Lobbying report
Amount
$90,000
Quarter
Q1 2026
Stock
AbbVie ABBV
Client
Abbvie
Reported
26/04/15

Up 12.5% from last quarter

What else happened in AbbVie around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Abbvie's other lobbying reports

  • Abbvie

    LobbyingAbbVie

    $50K

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $60K

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $1.2M

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $60K

    Reported 07/20

  • Abbvie

    LobbyingAbbVie

    $30K

    Reported 07/20

AbbVie ABBV paid Brownstein Hyatt Farber Schreck $90K for lobbying in Q1 2026 · Health Issues, Consumer Issues | Whalegun